VANDA PHARMACEUTICALS (VNDA) News Headlines

▮ More

Date

Headline

1/14/2022 9:21:48 AM Vanda Settles HETLIOZ Patent Litigation With MSN

1/14/2022 8:38:37 AM Vanda Pharma Settles HETLIOZ Patent Litigation With MSN

8/3/2021 7:21:22 AM Vanda Closes Enrollment In ODYSSEY Study Comparing Tradipitant And Placebo In Hospitalized COVID-19 Pneumonia Patients

12/2/2020 2:11:23 AM OVID Plunges, VNDA's Hetlioz Scores Another FDA Nod, Auris Investors Smile Ear To Ear

11/29/2020 8:12:00 PM Biotech Stocks Facing FDA Decision In December 2020

9/1/2020 12:00:44 AM ACST's CaPre Misses Goal Again, AIMT Snapped Up By Nestle, CRMD To Face FDA In Feb, VIR & COVID-19

8/19/2020 12:29:27 AM ALBO Drops NASH Drug Development, FDA Says No To Filgotinib, SUPN On Watch, Vanda & ODYSSEY

8/18/2020 7:58:50 AM Vanda : Interim Study Shows Tradipitant Accelerates Improvement In Patients With COVID-19 Pneumonia

8/18/2020 7:14:09 AM Vanda Pharma: Interim Analysis Of ODYSSEY Study Shows Tradipitant May Accelerate Clinical Improvement

8/4/2020 3:31:42 AM ALRN To Report Data In Q4, IMUC Hits New High, VYGR Pulls Out Of ABBV Deal, VNDA To Face FDA In Dec.

8/3/2020 7:15:24 AM Vanda Says FDA Accepted For Priority Review Applications For Smith-Magenis Syndrome

7/14/2020 2:30:51 AM EQ Soars, INMB Up On Promising Alzheimer's Trial Data, ALT To Move AdCOVID Into Clinical Trial In Q4

7/13/2020 4:36:18 PM FDA Grants Authorization For Individual Patient Expanded Access Protocol For The Use Of Tradipitant For Gastroparesis

5/20/2020 10:47:12 AM Vanda Pharma CEO's Proposal On Clinical Trial Data Sharing, COVID-19 And Remdesivir

5/13/2020 7:07:12 AM Vanda Pharma Agrees With FDA On Resubmission Of Application For HETLIOZ For Smith-Magenis Syndrome

4/16/2020 12:44:18 AM RCUS Abuzz, FDA Approves First Therapy For LG UTUC, VNDA Joins COVID-19 Battle

2/25/2020 10:08:37 PM IOVA Abuzz, SUPN Study Flops, IMV Plunges Despite Positive Ovarian Cancer Data

2/19/2020 7:03:45 AM Vanda Pharmaceuticals Appoints Stephen Ray Mitchell To Its Board

4/6/2018 8:53:19 AM Jefferies Is Cutting VANDA PHARMACEUTICALS (VNDA) 2020 Estimate To 0.61 From 0.67

4/6/2018 8:53:03 AM Jefferies Is Lowering VANDA PHARMACEUTICALS (VNDA) 2019 Estimate To 0.83 From 0.92

Vanda Pharmaceuticals (VNDA)